Xtant Medical Holdings, Inc. (XTNT) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2011: $9.11M2012: $10.34M2013: $14.19M2014: $13.03M2015: $20.26M2016: $27.71M2017: $32.51M2018: $28.72M2019: $22.17M2020: $18.95M2021: $22.77M2022: $25.83M2023: $35.84M2024: $49.05M2025: $49.65M$49.65M
2011Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$49.65M+1.2%
2024$49.05M+36.9%
2023$35.84M+38.7%
2022$25.83M+13.4%
2021$22.77M+20.2%
2020$18.95M-14.5%
2019$22.17M-22.8%
2018$28.72M-11.7%
2017$32.51M+17.3%
2016$27.71M+36.8%
2015$20.26M+55.5%
2014$13.03M-8.1%
2013$14.19M+37.2%
2012$10.34M+13.5%
2011$9.11M